GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

Recalled Excedrin with hole in the bottom of the bottle

Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets

Recall Date: December 23rd, 2020
Units: About 433,600
Hazards: Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).
Remedies: Refund
Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.

Description

This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued.

Images:

Recalled Excedrin with hole in the bottom of the bottle

Recalled Excedrin Migraine Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin Migraine Geltabs (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin Extra Strength Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin PM Headache Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Recalled Excedrin Tension Headache Caplets (50, 80, 100, 125, 200, 250 and 300-count)

Consumer Contact:

GSK Consumer Relations at 800-468-7746 from 8 a.m. to 6 p.m. ET Monday through Friday, or online at www.excedrin.com and click on the “safety issue” banner at the top of the page for more information.